The treatment of Cellulite & Fibrocystic Breast Disease with vitamins

Cellulite and Fibrocystic Breast Disease: Mitamins custom make quality formulas for the treatment of Cellulite & Fibrocystic Breast Disease with vitamins. A Cellulite & Fibrocystic Breast Disease formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Cellulite and Fibrocystic Breast Disease

  • Amount Per Serving
    % DV
    Vitamin C
    100
    mg
    167%
    Vitamin E
    200
    IU
    667%
    Vitamin B6
    50
    mg
    2500%
    Magnesium
    100
    mg
    25%
    Choline Bitartrate
    50
    mg
    *
    Inositol
    50
    mg
    *
  • Amount Per Serving
    % DV
    Flax Seed Powder
    50
    mg
    *
    Ginkgo Extract
    40
    mg
    *
    L-Carnitine
    100
    mg
    *
    Conjugated Linoleic Acid
    150
    mg
    *
    Cayenne Extract
    100
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Cellulite and Fibrocystic Breast Disease
Serving Size:4-5

Cellulite and Fibrocystic Breast Disease Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Siemens Japan Acquires Majority Stake Of Mochida Siemens Medical Systems
Mochida Pharmaceutical Co., Ltd., and Siemens K.K. Japan have agreed to change the ownership interest both companies hold in their joint venture Mochida Siemens Medical Systems Co., Ltd. Mochida Pharmaceutical transferred 16 percent of its outstanding shares to Siemens K.K., making Siemens K.K. a 51 percent equity stakeholder. The share transfer means that Mochida Siemens Medical Systems Co., Ltd.
Controversial Anemia Drug Doesn't Cut Need for Transfusions (HealthDay)
A drug widely used to treat anemia does not reduce the need for blood transfusions among critically ill patients, but it may reduce mortality in trauma patients.
This information concerning the support of Cellulite and Fibrocystic Breast Disease treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments